Logo

Kevin Krenitsky, Timothy Dec

Apr 17, 2015

OpGen announced two new appointments to the firm, including the appointment of Kevin Krenitsky as president. He takes over the role from Evan Jones, who will remain CEO and chairman of OpGen, according to a document filed with the US Securities and Exchange Commission. Krenitsky joins the company, which filed for an initial public offering last month, from Foundation Medicine, where he was chief commercial officer and senior vice president of international strategy. Before that, he was president of Enzo Clinical Labs. 

Also, OpGen named Timothy Dec as its interim CFO, effective April 22. He replaces Eric Winzer, who resigned from OpGen, effective May 1. Dec has been CFO and SVP of Clubwidesports, a sports management software firm. Prior to that, he was CFO and SVP of Fortress International. 

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.